Published in Toxicol Appl Pharmacol on May 01, 1981
Male-mediated developmental toxicity. Annu Rev Public Health (1993) 1.31
Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop. Toxicol Sci (2001) 1.30
Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam Appl Toxicol (1994) 1.28
Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell (1995) 1.25
Dose-response assessment for developmental toxicity. III. Statistical models. Fundam Appl Toxicol (1994) 1.18
Ras oncogene mutations in childhood brain tumors. Cancer Epidemiol Biomarkers Prev (1997) 1.12
Stimulating research to improve the scientific basis of risk assessment. Toxicol Sci (1999) 1.11
Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ Health Perspect (1998) 1.10
Use of quality-adjusted life year weights with dose-response models for public health decisions: a case study of the risks and benefits of fish consumption. Risk Anal (2000) 1.08
Semen quality of men employed at a lead smelter. Occup Environ Med (1996) 1.07
Human variability in mercury toxicokinetics and steady state biomarker ratios. Environ Res (2000) 1.02
Organophosphate pesticide metabolite levels in pre-school children in an agricultural community: within- and between-child variability in a longitudinal study. Environ Res (2011) 1.02
Safety assessment of allylalkoxybenzene derivatives used as flavouring substances - methyl eugenol and estragole. Food Chem Toxicol (2002) 1.00
Unusually high levels of carcinogenic tobacco-specific nitrosamines in Sudan snuff (toombak). Carcinogenesis (1991) 0.99
The FEMA GRAS assessment of pyrazine derivatives used as flavor ingredients. Flavor and Extract Manufacturers Association. Food Chem Toxicol (2002) 0.96
Hypomethylation of DNA: an epigenetic mechanism involved in tumor promotion. Mol Carcinog (1994) 0.96
Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis (1995) 0.94
Gonadotropin regulation of glutathione synthesis in the rat ovary. Reprod Toxicol (2002) 0.94
Workshop overview. National Toxicology Program Studies: principles of dose selection and applications to mechanistic based risk assessment. Fundam Appl Toxicol (1996) 0.93
Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention. Risk Anal (2000) 0.92
Effects of methyl mercury on the cell cycle of primary rat CNS cells in vitro. Toxicol Appl Pharmacol (1994) 0.92
The role of hepatic microbody and soluble oxidases in the peroxidation of methanol in the rat and monkey. Mol Pharmacol (1968) 0.91
The FEMA GRAS assessment of trans-anethole used as a flavouring substance. Flavour and Extract Manufacturer's Association. Food Chem Toxicol (1999) 0.91
Infection of rat liver epithelial cells with v-Ha-ras: correlation between oncogene expression, gap junctional communication, and tumorigenicity. Mol Carcinog (1990) 0.89
Effect of methylmercury on midbrain cell proliferation during organogenesis: potential cross-species differences and implications for risk assessment. Toxicol Sci (2003) 0.88
Altered methylation of ras oncogenes in benzidine-induced B6C3F1 mouse liver tumors. Toxicol Appl Pharmacol (1989) 0.87
Comparison of effect of tumor promoter treatments on DNA methylation status and gene expression in B6C3F1 and C57BL/6 mouse liver and in B6C3F1 mouse liver tumors. Mol Carcinog (1997) 0.86
Consideration of cultural and lifestyle factors in defining susceptible populations for environmental disease. Toxicology (2004) 0.86
Intercellular communication may facilitate apoptosis: implications for tumor promotion. Mol Carcinog (1994) 0.85
DNA-purine methylation in hepatic chromatin following exposure to dimethylnitrosamine or methylnitrosourea. Biochem Pharmacol (1984) 0.85
A method for the rapid quantitation of methylated hepatic DNA-purines using high pressure liquid chromatography. J Pharmacol Methods (1980) 0.85
Comparative studies on the neuro- and reproductive toxicity of acrylamide and its epoxide metabolite glycidamide in the rat. Neurotoxicology (1992) 0.85
Nitrosatable drug exposure during pregnancy and adverse pregnancy outcome. Int J Epidemiol (1989) 0.85
Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors. Mol Carcinog (1994) 0.84
Maternal exposure to N-nitrosatable drugs as a risk factor for childhood brain tumours. Int J Epidemiol (1995) 0.84
Induction of the cell cycle regulatory gene p21 (Waf1, Cip1) following methylmercury exposure in vitro and in vivo. Toxicol Appl Pharmacol (1999) 0.83
A comparison of rat and human liver formaldehyde dehydrogenase. Biochim Biophys Acta (1971) 0.83
Simultaneous analysis of surface marker expression and cell cycle progression in human peripheral blood mononuclear cells. J Immunol Methods (2001) 0.83
The role of intracellular glutathione in methylmercury-induced toxicity in embryonic neuronal cells. Neurotoxicology (1999) 0.83
A biologically-based dose-response model for developmental toxicology. Risk Anal (1996) 0.82
Role of the intracellular distribution of hepatic catalase in the peroxidative oxidation of methanol. Ann N Y Acad Sci (1969) 0.82
Studies on the mechanism of inhibition of 2-acetylaminofluorene toxicity by butylated hydroxytoluene. Chem Biol Interact (1976) 0.82
Induction of growth arrest and DNA damage-inducible genes Gadd45 and Gadd153 in primary rodent embryonic cells following exposure to methylmercury. Toxicol Appl Pharmacol (1997) 0.82
A systems-based computational model for dose-response comparisons of two mode of action hypotheses for ethanol-induced neurodevelopmental toxicity. Toxicol Sci (2005) 0.81
Factors influencing the binding of N-2-fluorenylacetamide to specific regions of the hepatic genome in vivo in rats. J Natl Cancer Inst (1981) 0.81
Effects of benzimidazole analogs on cultures of differentiating rodent embryonic cells. Toxicol Appl Pharmacol (1992) 0.81
Hypomethylation of DNA: a nongenotoxic mechanism involved in tumor promotion. Toxicol Lett (1995) 0.81
Assessment of PCB congener analytical methods: do they meet risk assessment needs? Arch Environ Contam Toxicol (2003) 0.81
Methylmercury distribution in the pregnant rat and embryo during early midbrain organogenesis. Teratology (2002) 0.80
Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors. J Toxicol Environ Health (1991) 0.80
Weighing the risks and the benefits: a call for the empirical assessment of perceived teratogenic risk. Reprod Toxicol (1997) 0.80
Lipid mediator production by post-implantation rat embryos in vitro. Prostaglandins (1989) 0.80
Modulation of nitrosourea toxicity in rodent embryonic cells by O6-benzylguanine, a depletor of O6-methylguanine-DNA methyltransferase. Toxicol Appl Pharmacol (1995) 0.80
A computational model for neocortical neuronogenesis predicts ethanol-induced neocortical neuron number deficits. Dev Neurosci (2002) 0.80
Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: dose influences mechanism. Regul Toxicol Pharmacol (1995) 0.80
Polybrominated biphenyls as promoters in experimental hepatocarcinogenesis in rats. Carcinogenesis (1982) 0.80
Effects of thallium on primary cultures of testicular cells. J Toxicol Environ Health (1992) 0.80
Characterization of cytoskeletal and neuronal markers in micromass cultures of rat embryonic midbrain cells. Cell Biol Toxicol (1994) 0.80
Cell specificity in DNA binding and repair of chemical carcinogens. Environ Health Perspect (1983) 0.79
Reproductive endocrine effects of acute exposure to toluene in men and women. Occup Environ Med (1999) 0.79
Quantitative mechanistically based dose-response modeling with endocrine-active compounds. Environ Health Perspect (1999) 0.79
Dose-response assessments for developmental toxicity. IV. Benchmark doses for fetal weight changes. Fundam Appl Toxicol (1995) 0.79
Diabetic anhidrosis. Am J Med (1966) 0.79
Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis (1992) 0.79
Trichloroethylene: toxicology and health hazards. G Ital Med Lav (1993) 0.79
The FEMA GRAS assessment of hydroxy- and alkoxy-substituted benzyl derivatives used as flavor ingredients. Food Chem Toxicol (2005) 0.78
Hypomethylation of DNA: a possible epigenetic mechanism involved in tumor promotion. Prog Clin Biol Res (1995) 0.78
Inhibition of methanol and ethanol oxidation by pyrazole in the rat and monkey in vivo. Mol Pharmacol (1970) 0.78
Investigation of parameters associated with activity of the Kirsten-ras, Harvey-ras, and myc oncogenes in normal rat liver. Toxicol Appl Pharmacol (1987) 0.78
Inhibition of N-2-fluorenylacetamide-induced mammary tumorigenesis in rats by dietary polybrominated biphenyls. J Natl Cancer Inst (1980) 0.78
Repeated inhalation exposure to octamethylcyclotetrasiloxane produces hepatomegaly, transient hepatic hyperplasia, and sustained hypertrophy in female Fischer 344 rats in a manner similar to phenobarbital. Toxicol Appl Pharmacol (2001) 0.78
Uncertainty analysis methods for comparing predictive models and biomarkers: A case study of dietary methyl mercury exposure. Regul Toxicol Pharmacol (1998) 0.78
The FEMA GRAS assessment of furfural used as a flavour ingredient. Flavor and Extract Manufacturers' Association. Food Chem Toxicol (1997) 0.78
Quantitative studies on metabolic activation in vitro employing benzo[a]pyrene as the test compound. Mutat Res (1983) 0.77
The FEMA GRAS assessment of benzyl derivatives used as flavor ingredients. Food Chem Toxicol (2005) 0.77
RNA synthesis and RNA polymerase activity in hepatic nuclei isolated from rats fed the carcinogen 2-acetylaminofluorene. Biochem Biophys Res Commun (1976) 0.77
Comparative risk and policy analysis in environmental health. Risk Anal (2003) 0.77
Effects of albendazole and albendazole sulfoxide on cultures of differentiating rodent embryonic cells. Toxicol Appl Pharmacol (1991) 0.77
Methylation of the serum albumin gene as compared to the Kirsten-ras oncogene in hepatocytes and non-parenchymal cells of rat liver. Biochem Biophys Res Commun (1985) 0.77
The FEMA GRAS assessment of phenethyl alcohol, aldehyde, acid, and related acetals and esters used as flavor ingredients. Food Chem Toxicol (2005) 0.77
A procedure for the safety evaluation of natural flavor complexes used as ingredients in food: essential oils. Food Chem Toxicol (2005) 0.76
Evaluation of P19 cells for studying mechanisms of developmental toxicity: application to four direct-acting alkylating agents. Toxicology (1998) 0.76
Hepatic tumor-promoting ability of 3,3',4,4',5,5'-hexabromobiphenyl: the interrelationship between toxicity, induction of hepatic microsomal drug metabolizing enzymes, and tumor-promoting ability. Toxicol Appl Pharmacol (1983) 0.76
U.S. Environmental Protection Agency's revised cancer guidelines for carcinogen risk assessment. Toxicol Appl Pharmacol (1998) 0.76
Contrasting associations of blood and semen lead concentrations with semen quality among lead smelter workers. Am J Ind Med (1998) 0.76
Toxicity was defined as any deleterious change that was discerned by histopathology. Mol Carcinog (1992) 0.75
Quantitative studies on the in vitro metabolic activation of dimethylnitrosamine by rat liver postmitochondrial supernatant. Environ Health Perspect (1984) 0.75
Comments on "Why not use it all?". Environ Health Perspect (1999) 0.75
Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds. Toxicol Sci (2000) 0.75
Rodent toxicity and nongenotoxic carcinogenesis: knowledge-based human risk assessment based on molecular mechanisms. Toxicol Mech Methods (2003) 0.75
Re: androgen receptor antagonism by the organophosphate insecticide fenitrothion. Toxicol Sci (2001) 0.75
Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors. Mol Toxicol (1990) 0.75
Effects of styrene oxide on differentiation and viability of rodent embryo cultures. Toxicol Appl Pharmacol (1994) 0.75
Non-random nature of 2-acetylaminofluorene-induced alterations of DNA template capacity. Chem Biol Interact (1979) 0.75
Effects of O6-benzylguanine on growth and differentiation of P19 embryonic carcinoma cells treated with alkylating agents. Teratog Carcinog Mutagen (1998) 0.75
Comments on "An approach for modeling noncancer dose responses with an emphasis on uncertainty" and "A probabilistic framework for the Reference Dose (probabilistic RfD)". Risk Anal (1998) 0.75
Quantitative and qualitative aspects of the binding of N-hydroxy-2-acetylaminofluorene to hepatic chromatin fractions. Chem Biol Interact (1979) 0.75
Alterations in the methylation status of ras oncogenes in B6C3F1 mouse liver tumors. Prog Clin Biol Res (1990) 0.75